1 Study Coverage 1.1 Cephalexin Capsules Product Introduction 1.2 Market by Type 1.2.1 Global Cephalexin Capsules Market Size Growth Rate by Type 1.2.2 125mg 1.2.3 250mg 1.2.4 500mg 1.3 Market by Application 1.3.1 Global Cephalexin Capsules Market Size Growth Rate by Application 1.3.2 Respiratory Tract Infection 1.3.3 Skin and Soft Tissue Infections 1.3.4 Urinary Tract Infection 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Cephalexin Capsules Market Size, Estimates and Forecasts 2.1.1 Global Cephalexin Capsules Revenue 2016-2027 2.1.2 Global Cephalexin Capsules Sales 2016-2027 2.2 Global Cephalexin Capsules, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Cephalexin Capsules Historical Market Size by Region (2016-2021) 2.3.1 Global Cephalexin Capsules Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Cephalexin Capsules Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Cephalexin Capsules Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Cephalexin Capsules Sales Forecast by Region (2022-2027) 2.4.2 Global Cephalexin Capsules Revenue Forecast by Region (2022-2027) 3 Global Cephalexin Capsules Competitor Landscape by Players 3.1 Global Top Cephalexin Capsules Manufacturers by Sales 3.1.1 Global Cephalexin Capsules Sales by Manufacturer (2016-2021) 3.1.2 Global Cephalexin Capsules Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Cephalexin Capsules Manufacturers by Revenue 3.2.1 Key Cephalexin Capsules Manufacturers Covered: Ranking by Revenue 3.2.2 Global Cephalexin Capsules Revenue by Manufacturers (2016-2021) 3.2.3 Global Cephalexin Capsules Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Cephalexin Capsules Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Cephalexin Capsules Revenue in 2020 3.2.6 Global Cephalexin Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Cephalexin Capsules Price by Manufacturers 3.4 Global Cephalexin Capsules Manufacturing Base Distribution, Product Types 3.4.1 Cephalexin Capsules Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Cephalexin Capsules Product Type 3.4.3 Date of International Manufacturers Enter into Cephalexin Capsules Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Cephalexin Capsules Market Size by Type (2016-2021) 4.1.1 Global Cephalexin Capsules Sales by Type (2016-2021) 4.1.2 Global Cephalexin Capsules Revenue by Type (2016-2021) 4.1.3 Cephalexin Capsules Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Cephalexin Capsules Market Size Forecast by Type (2022-2027) 4.2.1 Global Cephalexin Capsules Sales Forecast by Type (2022-2027) 4.2.2 Global Cephalexin Capsules Revenue Forecast by Type (2022-2027) 4.2.3 Cephalexin Capsules Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Cephalexin Capsules Market Size by Application (2016-2021) 5.1.1 Global Cephalexin Capsules Sales by Application (2016-2021) 5.1.2 Global Cephalexin Capsules Revenue by Application (2016-2021) 5.1.3 Cephalexin Capsules Price by Application (2016-2021) 5.2 Cephalexin Capsules Market Size Forecast by Application (2022-2027) 5.2.1 Global Cephalexin Capsules Sales Forecast by Application (2022-2027) 5.2.2 Global Cephalexin Capsules Revenue Forecast by Application (2022-2027) 5.2.3 Global Cephalexin Capsules Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Cephalexin Capsules Market Size YoY Growth 2016-2027 6.1.1 United States Cephalexin Capsules Sales YoY Growth 2016-2027 6.1.2 United States Cephalexin Capsules Revenue YoY Growth 2016-2027 6.1.3 United States Cephalexin Capsules Market Share in Global Market 2016-2027 6.2 United States Cephalexin Capsules Market Size by Players (International and Local Players) 6.2.1 United States Top Cephalexin Capsules Players by Sales (2016-2021) 6.2.2 United States Top Cephalexin Capsules Players by Revenue (2016-2021) 6.3 United States Cephalexin Capsules Historic Market Review by Type (2016-2021) 6.3.1 United States Cephalexin Capsules Sales Market Share by Type (2016-2021) 6.3.2 United States Cephalexin Capsules Revenue Market Share by Type (2016-2021) 6.3.3 United States Cephalexin Capsules Price by Type (2016-2021) 6.4 United States Cephalexin Capsules Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Cephalexin Capsules Sales Forecast by Type (2022-2027) 6.4.2 United States Cephalexin Capsules Revenue Forecast by Type (2022-2027) 6.4.3 United States Cephalexin Capsules Price Forecast by Type (2022-2027) 6.5 United States Cephalexin Capsules Historic Market Review by Application (2016-2021) 6.5.1 United States Cephalexin Capsules Sales Market Share by Application (2016-2021) 6.5.2 United States Cephalexin Capsules Revenue Market Share by Application (2016-2021) 6.5.3 United States Cephalexin Capsules Price by Application (2016-2021) 6.6 United States Cephalexin Capsules Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Cephalexin Capsules Sales Forecast by Application (2022-2027) 6.6.2 United States Cephalexin Capsules Revenue Forecast by Application (2022-2027) 6.6.3 United States Cephalexin Capsules Price Forecast by Application (2022-2027) 7 North America 7.1 North America Cephalexin Capsules Market Size YoY Growth 2016-2027 7.2 North America Cephalexin Capsules Market Facts & Figures by Country 7.2.1 North America Cephalexin Capsules Sales by Country (2016-2021) 7.2.2 North America Cephalexin Capsules Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Cephalexin Capsules Market Size YoY Growth 2016-2027 8.2 Asia Pacific Cephalexin Capsules Market Facts & Figures by Region 8.2.1 Asia Pacific Cephalexin Capsules Sales by Region (2016-2021) 8.2.2 Asia Pacific Cephalexin Capsules Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Cephalexin Capsules Market Size YoY Growth 2016-2027 9.2 Europe Cephalexin Capsules Market Facts & Figures by Country 9.2.1 Europe Cephalexin Capsules Sales by Country (2016-2021) 9.2.2 Europe Cephalexin Capsules Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Cephalexin Capsules Market Size YoY Growth 2016-2027 10.2 Latin America Cephalexin Capsules Market Facts & Figures by Country 10.2.1 Latin America Cephalexin Capsules Sales by Country (2016-2021) 10.2.2 Latin America Cephalexin Capsules Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Cephalexin Capsules Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Cephalexin Capsules Market Facts & Figures by Country 11.2.1 Middle East and Africa Cephalexin Capsules Sales by Country (2016-2021) 11.2.2 Middle East and Africa Cephalexin Capsules Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 GSK 12.1.1 GSK Corporation Information 12.1.2 GSK Description and Business Overview 12.1.3 GSK Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GSK Cephalexin Capsules Products Offered 12.1.5 GSK Recent Development 12.2 Abbot 12.2.1 Abbot Corporation Information 12.2.2 Abbot Description and Business Overview 12.2.3 Abbot Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Abbot Cephalexin Capsules Products Offered 12.2.5 Abbot Recent Development 12.3 Sun Pharma 12.3.1 Sun Pharma Corporation Information 12.3.2 Sun Pharma Description and Business Overview 12.3.3 Sun Pharma Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sun Pharma Cephalexin Capsules Products Offered 12.3.5 Sun Pharma Recent Development 12.4 Teva 12.4.1 Teva Corporation Information 12.4.2 Teva Description and Business Overview 12.4.3 Teva Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Teva Cephalexin Capsules Products Offered 12.4.5 Teva Recent Development 12.5 Cipla 12.5.1 Cipla Corporation Information 12.5.2 Cipla Description and Business Overview 12.5.3 Cipla Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Cipla Cephalexin Capsules Products Offered 12.5.5 Cipla Recent Development 12.6 Cadila Healthcare 12.6.1 Cadila Healthcare Corporation Information 12.6.2 Cadila Healthcare Description and Business Overview 12.6.3 Cadila Healthcare Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Cadila Healthcare Cephalexin Capsules Products Offered 12.6.5 Cadila Healthcare Recent Development 12.7 Dr Reddy's Laboratories 12.7.1 Dr Reddy's Laboratories Corporation Information 12.7.2 Dr Reddy's Laboratories Description and Business Overview 12.7.3 Dr Reddy's Laboratories Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Dr Reddy's Laboratories Cephalexin Capsules Products Offered 12.7.5 Dr Reddy's Laboratories Recent Development 12.8 Aurobindo Pharma 12.8.1 Aurobindo Pharma Corporation Information 12.8.2 Aurobindo Pharma Description and Business Overview 12.8.3 Aurobindo Pharma Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Aurobindo Pharma Cephalexin Capsules Products Offered 12.8.5 Aurobindo Pharma Recent Development 12.9 Innova Captab 12.9.1 Innova Captab Corporation Information 12.9.2 Innova Captab Description and Business Overview 12.9.3 Innova Captab Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Innova Captab Cephalexin Capsules Products Offered 12.9.5 Innova Captab Recent Development 12.10 Alkem Laboratories 12.10.1 Alkem Laboratories Corporation Information 12.10.2 Alkem Laboratories Description and Business Overview 12.10.3 Alkem Laboratories Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Alkem Laboratories Cephalexin Capsules Products Offered 12.10.5 Alkem Laboratories Recent Development 12.11 GSK 12.11.1 GSK Corporation Information 12.11.2 GSK Description and Business Overview 12.11.3 GSK Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.11.4 GSK Cephalexin Capsules Products Offered 12.11.5 GSK Recent Development 12.12 Lupin 12.12.1 Lupin Corporation Information 12.12.2 Lupin Description and Business Overview 12.12.3 Lupin Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Lupin Products Offered 12.12.5 Lupin Recent Development 12.13 Orchid Pharma 12.13.1 Orchid Pharma Corporation Information 12.13.2 Orchid Pharma Description and Business Overview 12.13.3 Orchid Pharma Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Orchid Pharma Products Offered 12.13.5 Orchid Pharma Recent Development 12.14 Karalex Pharma 12.14.1 Karalex Pharma Corporation Information 12.14.2 Karalex Pharma Description and Business Overview 12.14.3 Karalex Pharma Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Karalex Pharma Products Offered 12.14.5 Karalex Pharma Recent Development 12.15 Shanghai Hengshan Pharmaceutical 12.15.1 Shanghai Hengshan Pharmaceutical Corporation Information 12.15.2 Shanghai Hengshan Pharmaceutical Description and Business Overview 12.15.3 Shanghai Hengshan Pharmaceutical Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Shanghai Hengshan Pharmaceutical Products Offered 12.15.5 Shanghai Hengshan Pharmaceutical Recent Development 12.16 Jilin Huinan Sanhe Pharmaceutical 12.16.1 Jilin Huinan Sanhe Pharmaceutical Corporation Information 12.16.2 Jilin Huinan Sanhe Pharmaceutical Description and Business Overview 12.16.3 Jilin Huinan Sanhe Pharmaceutical Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Jilin Huinan Sanhe Pharmaceutical Products Offered 12.16.5 Jilin Huinan Sanhe Pharmaceutical Recent Development 12.17 Jilin Daojun Pharmaceutical 12.17.1 Jilin Daojun Pharmaceutical Corporation Information 12.17.2 Jilin Daojun Pharmaceutical Description and Business Overview 12.17.3 Jilin Daojun Pharmaceutical Cephalexin Capsules Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Jilin Daojun Pharmaceutical Products Offered 12.17.5 Jilin Daojun Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Cephalexin Capsules Industry Trends 13.2 Cephalexin Capsules Market Drivers 13.3 Cephalexin Capsules Market Challenges 13.4 Cephalexin Capsules Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Cephalexin Capsules Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Cephalexin Capsules Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 125mg Table 3. Major Manufacturers of 250mg Table 4. Major Manufacturers of 500mg Table 5. Global Cephalexin Capsules Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Cephalexin Capsules Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Cephalexin Capsules Sales by Regions (2016-2021) & (K Units) Table 8. Global Cephalexin Capsules Sales Market Share by Regions (2016-2021) Table 9. Global Cephalexin Capsules Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Cephalexin Capsules Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Cephalexin Capsules Sales Market Share Forecast by Region (2022-2027) Table 12. Global Cephalexin Capsules Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Cephalexin Capsules Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Cephalexin Capsules Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Cephalexin Capsules Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Cephalexin Capsules Manufacturers by Revenue (US$ Million) in 2020 Table 17. Cephalexin Capsules Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Cephalexin Capsules Revenue Share by Manufacturers (2016-2021) Table 19. Global Cephalexin Capsules Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Cephalexin Capsules by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cephalexin Capsules as of 2020) Table 21. Key Manufacturers Cephalexin Capsules Price (2016-2021) (US$/Unit) Table 22. Cephalexin Capsules Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Cephalexin Capsules Product Type Table 24. Date of International Manufacturers Enter into Cephalexin Capsules Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Cephalexin Capsules Sales by Type (2016-2021) (K Units) Table 27. Global Cephalexin Capsules Sales Share by Type (2016-2021) Table 28. Global Cephalexin Capsules Revenue by Type (2016-2021) (US$ Million) Table 29. Global Cephalexin Capsules Revenue Share by Type (2016-2021) Table 30. Cephalexin Capsules Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 31. Global Cephalexin Capsules Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Cephalexin Capsules Sales Market Share Forecast by Type (2022-2027) Table 33. Global Cephalexin Capsules Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Cephalexin Capsules Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Cephalexin Capsules Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Cephalexin Capsules Sales by Application (2016-2021) (K Units) Table 37. Global Cephalexin Capsules Sales Share by Application (2016-2021) Table 38. Global Cephalexin Capsules Revenue by Application (2016-2021) (US$ Million) Table 39. Global Cephalexin Capsules Revenue Share by Application (2016-2021) Table 40. Cephalexin Capsules Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 41. Global Cephalexin Capsules Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Cephalexin Capsules Sales Market Share Forecast by Application (2022-2027) Table 43. Global Cephalexin Capsules Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Cephalexin Capsules Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Cephalexin Capsules Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 46. United States Cephalexin Capsules Sales (K Units) of Key Companies (2016-2021) Table 47. United States Cephalexin Capsules Sales Share by Company (2016-2021) Table 48. United States Cephalexin Capsules Revenue (US$ Million) by Company (2016-2021) Table 49. United States Cephalexin Capsules Revenue Share by Company (2016-2021) Table 50. United States Cephalexin Capsules Sales (K Units) by Type (2016-2021) Table 51. United States Cephalexin Capsules Sales Share by Type (2016-2021) Table 52. United States Cephalexin Capsules Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. United States Cephalexin Capsules Price (US$/Unit) by Type (2016-2021) Table 54. United States Cephalexin Capsules Sales (K Units) by Type (2022-2027) Table 55. United States Cephalexin Capsules Sales Share by Type (2022-2027) Table 56. United States Cephalexin Capsules Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. United States Cephalexin Capsules Revenue Share by Type (2022-2027) Table 58. United States Cephalexin Capsules Price (US$/Unit) by Type (2022-2027) Table 59. United States Cephalexin Capsules Sales (K Units) by Application (2016-2021) Table 60. United States Cephalexin Capsules Sales Share by Application (2016-2021) Table 61. United States Cephalexin Capsules Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. United States Cephalexin Capsules Price (US$/Unit) by Application (2016-2021) Table 63. United States Cephalexin Capsules Sales (K Units) by Application (2022-2027) Table 64. United States Cephalexin Capsules Sales Share by Application (2022-2027) Table 65. United States Cephalexin Capsules Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. United States Cephalexin Capsules Revenue Share by Application (2022-2027) Table 67. United States Cephalexin Capsules Price (US$/Unit) by Application (2022-2027) Table 68. North America Cephalexin Capsules Sales by Country (2016-2021) & (K Units) Table 69. North America Cephalexin Capsules Sales Market Share by Country (2016-2021) Table 70. North America Cephalexin Capsules Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Cephalexin Capsules Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Cephalexin Capsules Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Cephalexin Capsules Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Cephalexin Capsules Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Cephalexin Capsules Revenue Market Share by Region (2016-2021) Table 76. Europe Cephalexin Capsules Sales by Country (2016-2021) & (K Units) Table 77. Europe Cephalexin Capsules Sales Market Share by Country (2016-2021) Table 78. Europe Cephalexin Capsules Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Cephalexin Capsules Revenue Market Share by Country (2016-2021) Table 80. Latin America Cephalexin Capsules Sales by Country (2016-2021) & (K Units) Table 81. Latin America Cephalexin Capsules Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Cephalexin Capsules Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Cephalexin Capsules Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Cephalexin Capsules Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Cephalexin Capsules Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Cephalexin Capsules Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Cephalexin Capsules Revenue Market Share by Country (2016-2021) Table 88. GSK Corporation Information Table 89. GSK Description and Business Overview Table 90. GSK Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. GSK Cephalexin Capsules Product Table 92. GSK Recent Development Table 93. Abbot Corporation Information Table 94. Abbot Description and Business Overview Table 95. Abbot Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Abbot Product Table 97. Abbot Recent Development Table 98. Sun Pharma Corporation Information Table 99. Sun Pharma Description and Business Overview Table 100. Sun Pharma Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Sun Pharma Product Table 102. Sun Pharma Recent Development Table 103. Teva Corporation Information Table 104. Teva Description and Business Overview Table 105. Teva Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Teva Product Table 107. Teva Recent Development Table 108. Cipla Corporation Information Table 109. Cipla Description and Business Overview Table 110. Cipla Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Cipla Product Table 112. Cipla Recent Development Table 113. Cadila Healthcare Corporation Information Table 114. Cadila Healthcare Description and Business Overview Table 115. Cadila Healthcare Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Cadila Healthcare Product Table 117. Cadila Healthcare Recent Development Table 118. Dr Reddy's Laboratories Corporation Information Table 119. Dr Reddy's Laboratories Description and Business Overview Table 120. Dr Reddy's Laboratories Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Dr Reddy's Laboratories Product Table 122. Dr Reddy's Laboratories Recent Development Table 123. Aurobindo Pharma Corporation Information Table 124. Aurobindo Pharma Description and Business Overview Table 125. Aurobindo Pharma Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. Aurobindo Pharma Product Table 127. Aurobindo Pharma Recent Development Table 128. Innova Captab Corporation Information Table 129. Innova Captab Description and Business Overview Table 130. Innova Captab Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Innova Captab Product Table 132. Innova Captab Recent Development Table 133. Alkem Laboratories Corporation Information Table 134. Alkem Laboratories Description and Business Overview Table 135. Alkem Laboratories Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 136. Alkem Laboratories Product Table 137. Alkem Laboratories Recent Development Table 138. Ascend Laboratories Corporation Information Table 139. Ascend Laboratories Description and Business Overview Table 140. Ascend Laboratories Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 141. Ascend Laboratories Product Table 142. Ascend Laboratories Recent Development Table 143. Lupin Corporation Information Table 144. Lupin Description and Business Overview Table 145. Lupin Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 146. Lupin Product Table 147. Lupin Recent Development Table 148. Orchid Pharma Corporation Information Table 149. Orchid Pharma Description and Business Overview Table 150. Orchid Pharma Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 151. Orchid Pharma Product Table 152. Orchid Pharma Recent Development Table 153. Karalex Pharma Corporation Information Table 154. Karalex Pharma Description and Business Overview Table 155. Karalex Pharma Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 156. Karalex Pharma Product Table 157. Karalex Pharma Recent Development Table 158. Shanghai Hengshan Pharmaceutical Corporation Information Table 159. Shanghai Hengshan Pharmaceutical Description and Business Overview Table 160. Shanghai Hengshan Pharmaceutical Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 161. Shanghai Hengshan Pharmaceutical Product Table 162. Shanghai Hengshan Pharmaceutical Recent Development Table 163. Jilin Huinan Sanhe Pharmaceutical Corporation Information Table 164. Jilin Huinan Sanhe Pharmaceutical Description and Business Overview Table 165. Jilin Huinan Sanhe Pharmaceutical Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 166. Jilin Huinan Sanhe Pharmaceutical Product Table 167. Jilin Huinan Sanhe Pharmaceutical Recent Development Table 168. Jilin Daojun Pharmaceutical Corporation Information Table 169. Jilin Daojun Pharmaceutical Description and Business Overview Table 170. Jilin Daojun Pharmaceutical Cephalexin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 171. Jilin Daojun Pharmaceutical Product Table 172. Jilin Daojun Pharmaceutical Recent Development Table 173. Cephalexin Capsules Market Trends Table 174. Cephalexin Capsules Market Drivers Table 175. Cephalexin Capsules Market Challenges Table 176. Cephalexin Capsules Market Restraints Table 177. Cephalexin Capsules Customers List Table 178. Cephalexin Capsules Distributors List Table 179. Research Programs/Design for This Report Table 180. Key Data Information from Secondary Sources Table 181. Key Data Information from Primary Sources List of Figures Figure 1. Cephalexin Capsules Product Picture Figure 2. Global Cephalexin Capsules Sales Market Share by Type in 2020 & 2027 Figure 3. 125mg Product Picture Figure 4. 250mg Product Picture Figure 5. 500mg Product Picture Figure 6. Global Cephalexin Capsules Sales Market Share by Application in 2020 & 2027 Figure 7. Respiratory Tract Infection Figure 8. Skin and Soft Tissue Infections Figure 9. Urinary Tract Infection Figure 10. Other Figure 11. Cephalexin Capsules Report Years Considered Figure 12. Global Cephalexin Capsules Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Cephalexin Capsules Market Size 2016-2027 (US$ Million) Figure 14. Global Cephalexin Capsules Sales 2016-2027 (K Units) Figure 15. Global Cephalexin Capsules Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Cephalexin Capsules Sales Market Share by Region (2016-2021) Figure 17. Global Cephalexin Capsules Sales Market Share by Region in 2020 Figure 18. Global Cephalexin Capsules Revenue Market Share by Region (2016-2021) Figure 19. Global Cephalexin Capsules Revenue Market Share by Region in 2020 Figure 20. Global Cephalexin Capsules Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Cephalexin Capsules Revenue in 2020 Figure 22. Cephalexin Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Cephalexin Capsules Sales Market Share by Type (2016-2021) Figure 24. Global Cephalexin Capsules Sales Market Share by Type in 2020 Figure 25. Global Cephalexin Capsules Revenue Market Share by Type (2016-2021) Figure 26. Global Cephalexin Capsules Revenue Market Share by Type in 2020 Figure 27. Global Cephalexin Capsules Sales Market Share by Application (2016-2021) Figure 28. Global Cephalexin Capsules Sales Market Share by Application in 2020 Figure 29. Global Cephalexin Capsules Revenue Market Share by Application (2016-2021) Figure 30. Global Cephalexin Capsules Revenue Market Share by Application in 2020 Figure 31. United States Cephalexin Capsules Sales Growth Rate 2016-2027 (K Units) Figure 32. United States Cephalexin Capsules Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. United States Cephalexin Capsules Market Share in Global Market 2016-2027 Figure 34. United States 5 and 10 Largest Cephalexin Capsules Players Market Share by Revenue in Cephalexin Capsules in 2020 Figure 35. United States Cephalexin Capsules Revenue Share by Type (2016-2021) Figure 36. United States Cephalexin Capsules Revenue Growth Rate by Type in 2016 & 2020 Figure 37. United States Cephalexin Capsules Revenue Share by Application (2016-2021) Figure 38. United States Cephalexin Capsules Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Cephalexin Capsules Sales Growth Rate 2016-2021 (K Units) Figure 40. North America Cephalexin Capsules Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Cephalexin Capsules Sales Market Share by Country in 2020 Figure 42. North America Cephalexin Capsules Revenue Market Share by Country in 2020 Figure 43. U.S. Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 44. U.S. Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 46. Canada Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Cephalexin Capsules Sales Growth Rate 2016-2021 (K Units) Figure 48. Europe Cephalexin Capsules Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Cephalexin Capsules Sales Market Share by Country in 2020 Figure 50. Europe Cephalexin Capsules Revenue Market Share by Country in 2020 Figure 51. Germany Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 52. Germany Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 54. France Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 56. U.K. Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 58. Italy Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 60. Russia Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Cephalexin Capsules Sales Growth Rate 2016-2021 (K Units) Figure 62. Asia Pacific Cephalexin Capsules Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Cephalexin Capsules Sales Market Share by Region in 2020 Figure 64. Asia Pacific Cephalexin Capsules Revenue Market Share by Region in 2020 Figure 65. China Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 66. China Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 68. Japan Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 70. South Korea Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 72. India Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 74. Australia Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 76. Taiwan Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 78. Indonesia Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 80. Thailand Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 82. Malaysia Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 84. Philippines Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 86. Vietnam Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Cephalexin Capsules Sales Growth Rate 2016-2021 (K Units) Figure 88. Latin America Cephalexin Capsules Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Cephalexin Capsules Sales Market Share by Country in 2020 Figure 90. Latin America Cephalexin Capsules Revenue Market Share by Country in 2020 Figure 91. Mexico Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 92. Mexico Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 94. Brazil Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 96. Argentina Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Cephalexin Capsules Sales Growth Rate 2016-2021 (K Units) Figure 98. Middle East and Africa Cephalexin Capsules Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Cephalexin Capsules Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Cephalexin Capsules Revenue Market Share by Country in 2020 Figure 101. Turkey Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 102. Turkey Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 104. Saudi Arabia Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. UAE Cephalexin Capsules Sales Growth Rate (2016-2021) (K Units) Figure 106. UAE Cephalexin Capsules Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Cephalexin Capsules Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

GSK Abbot Sun Pharma Teva Cipla Cadila Healthcare Dr Reddy's Laboratories Aurobindo Pharma Innova Captab Alkem Laboratories Ascend Laboratories Lupin Orchid Pharma Karalex Pharma Shanghai Hengshan Pharmaceutical Jilin Huinan Sanhe Pharmaceutical Jilin Daojun Pharmaceutical